Search
for
Sort by
Research 31–60 of 1000+
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Referee report. For: Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania [version 1; peer review: 1 approved, 1 approved with reservations]
- Primary Chemoprevention Still Lacks Favor with General Physicians & Patients
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE
- Performance evaluation of large language models in bladder cancer patient education Q&A: a cross-sectional study
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- The dermatology consultant: A retrospective analysis of inpatient dermatology
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Provenge is Talk of GU Malignancies Congress
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Iron Deficiency Anemia Diagnosed in the Private Practice Setting,
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Cutaneous Reactions to Chemotherapeutic Agents
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Pleomorphic Appearance of Breast Cancer Cutaneous Metastases
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- A Prepatellar Soft Tissue Mass in a 56-Year-Old Man
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System